title: [Efficacy of ginsenosides combined with prednisone in patients with systemic lupus erythematosus: a prospective, randomized, double-blind, placebo-controlled trial].
abstract: BACKGROUND
  The side effects of glucocorticoid in treatment of systemic lupus erythematosus (SLE) have been the focus of debate, and our preliminary study indicates that ginsenosides can enhance the efficacy of dexamethasone.
  
  
  OBJECTIVE
  To observe the effects of ginsenosides combined with prednisone in SLE patients.
  
  
  METHODS
  A total of 60 SLE patients from Department of Rheumatology and Immunology, Changhai Hospital, Second Military Medical University, were randomly divided into treatment group and control group, with 30 patients in each group. Patients in the treatment group were given routine treatment with prednisone plus ginsenosides, while those in the control group were given routine treatment with prednisone plus placebo. They were all treated for 3 months.
  
  
  METHODS
  After three-month treatment, syndrome score in traditional Chinese medicine (TCM), total response rate and symptom improvement rate were measured and evaluated.
  
  
  RESULTS
  Twenty-eight cases in treatment group and twenty-seven cases in control group were included in analysis. The total response rates in the treatment group and control group were 89.28% and 66.67% respectively, and there was a significant difference between the two groups (P<0.05). After treatment, the TCM syndrome scores in the two groups were lower than those before treatment (P<0.01), and prednisone plus ginsenosides was better in decreasing the TCM syndrome score than prednisone plus placebo (P<0.05). The symptoms were improved in the treatment group as compared with the control group (P<0.05).
  
  
  CONCLUSIONS
  Prednisone combined with ginsenosides can increase the clinical effective rate and improve the clinical symptoms of SLE patients.
authors: Department of Acupuncture and Massage, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
authors: Yan-li
authors: YL
authors: You
authors: Ying-lu
authors: YL
authors: Feng
authors: Qing
authors: Q
authors: Cai
authors: Jian-long
authors: JL
authors: Guan
authors: Lan-ling
authors: LL
authors: Zhang
authors: Mei-juan
authors: MJ
authors: Xu
authors: Xia
authors: X
authors: Xu
authors: Chang-quan
authors: CQ
authors: Ling
mesh_terms: D000328:Adult; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D036145:Ginsenosides / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage* / Q000627:therapeutic use; D011446:Prospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D036145:Ginsenosides; D011241:Prednisone